Internal Medicine, Hematology & Oncology · Kennesaw, GA
NPI
1396034187
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
750 Townpark Ln NW
Kennesaw, GA, 30144
Phone (404) 365-0966
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
265 services
Medicare patients, 2024
28
Average age 67
Drug cost, 2024
$3.6M
1,848 prescriptions
Company payments, 2023
$73.25
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rekha A Kumbla was code 99214 (office e&m - established), 32 times for 16 patients. In total Rekha A Kumbla billed 265 services in 30 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 32 | 16 | $89.65 | $2,869 |
By year: 2022 $79K for 832 services; 2023 $15K for 766 services; 2024 $11K for 265 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rekha A Kumbla prescribed most often to Medicare patients was Anastrozole, with 158 prescriptions and refills. In total Rekha A Kumbla wrote 1,848 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 158 | 382 | 48 | $3,720 |
| Ondansetron Hcl Generic | 98 | 99 | 41 | $959 |
| Dexamethasone Generic | 93 | 98 | 37 | $1,247 |
| Prednisone Generic | 93 | 108 | 32 | $661 |
| Abiraterone Acetate Generic | 84 | 88 | 21 | $12K |
| Letrozole Generic | 75 | 161 | 20 | $1,202 |
| Tamoxifen Citrate Generic | 69 | 111 | 13 | $1,059 |
| Nivestym Filgrastim-Aafi | 50 | 50 | 15 | $36K |
| Exemestane Generic | 48 | 96 | 12 | $2,682 |
| Xarelto Rivaroxaban | 46 | 78 | 12 | $36K |
| Pradaxa Dabigatran Etexilate Mesylate | 40 | 80 | 12 | $7,978 |
| Hydroxyurea Generic | 39 | 51 | Under 11 | $837 |
| Eliquis Apixaban | 36 | 74 | 11 | $43K |
| Acyclovir Generic | 34 | 70 | 11 | $763 |
| Brukinsa Zanubrutinib | 31 | 31 | Under 11 | $379K |
Brand drugs: 437 claims; generic drugs: 1,411 claims; opioid claims: 126.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Rekha A Kumbla $73.25 ($73.25 in general payments such as food, travel and fees) from 1 company. The largest payer was Davol Inc. with $73.25.
| Company | Payments | Amount |
|---|---|---|
| Davol Inc. BDX | 1 | $73.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.